RNS Number:2334S
Profile Therapeutics PLC
19 November 2003


Immediate Release                                              19 November 2003



                            Profile Therapeutics plc


                        Result Of Annual General Meeting


Profile Therapeutics plc, which develops and commercialises specialist inhaled
therapies, held its Annual General Meeting yesterday at which all resolutions
were duly passed.



For further information, please contact:

Profile Therapeutics

John Lisle, Chief Executive                                  Tel: 0870 770 2000
John Ward, Finance Director


Buchanan Communications                                      Tel: 020 7466 5000

Tim Anderson
James Strong









                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
AGMFFUSUUSDSEFF